Literature DB >> 28222649

A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty.

Jatin Prakash1, Jong-Keun Seon2, Yong Jin Park2, Cheng Jin2, Eun-Kyoo Song2.   

Abstract

BACKGROUND: The efficacy of tranexamic acid to decrease post-operative blood loss and blood transfusion is well established in literature. However, the ideal mode of administration is debatable. Limited literature has compared all the available modes of administration including intravenous (IV), topical irrigation and retrograde through drain. We hypothesized that no difference would be present in either form of administration of tranexamic acid.
METHODS: Fifty patients in four groups were enrolled for study. Group 1 received drug intravenously, group 2 had topical washing with drug before closure, group 3 received drug after closure through drain and group 4 was control that received no tranexamic acid. Post-operative blood loss, calculated blood loss, haemoglobin drop, transfusion requirements and complications were studied for all four groups.
RESULTS: Tranexamic acid results in lower bleeding irrespective of the mode of administration compared to control group. Total loss at end of 5 days is similar in all tranexamic acid groups irrespective of method used to deliver the drug. Calculated blood loss and haemoglobin drop was minimum for IV and in patients who were administered drug retrograde through drain. Requirement for blood transfusion was found to be lower in all tranexamic acid patients compared to non-tranexamic acid group. The requirement was highest in topical wash group among all tranexamic acid groups.
CONCLUSION: We conclude that intra-articular administration through drain and IV administration are equally effective and superior to topical wash method in reducing blood loss, haemoglobin fall and transfusion requirements.

Entities:  

Keywords:  intra-articular; intravenous; topical; total knee arthroplasty; tranexamic acid

Mesh:

Substances:

Year:  2017        PMID: 28222649     DOI: 10.1177/2309499017693529

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  7 in total

1.  High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.

Authors:  Nattapol Tammachote; Raphi Raphiphan; Supakit Kanitnate
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-29

2.  Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Isabel Taeuber; Stephanie Weibel; Eva Herrmann; Vanessa Neef; Tobias Schlesinger; Peter Kranke; Leila Messroghli; Kai Zacharowski; Suma Choorapoikayil; Patrick Meybohm
Journal:  JAMA Surg       Date:  2021-04-14       Impact factor: 14.766

3.  Comparison of blood loss between intra-articular and intra-venous administration of tranexamic acid in primary total knee arthroplasty.

Authors:  Muhammad Suhail Amin; Muhammad Khurram Habib; Aziz Ur Rehman
Journal:  SICOT J       Date:  2020-06-17

4.  Intra-articular vs. intravenous administration: a meta-analysis of tranexamic acid in primary total knee arthroplasty.

Authors:  Jin Li; Ruikang Liu; Saroj Rai; Renhao Ze; Xin Tang; Pan Hong
Journal:  J Orthop Surg Res       Date:  2020-12-02       Impact factor: 2.359

5.  Prospective, randomised, controlled study on the efficacy and safety of different strategies of tranexamic acid with total blood loss, blood transfusion rate and thrombogenic biomarkers in total knee arthroplasty: study protocol.

Authors:  Yong Yang; Zheng Wang; Faxuan Wang; Xin Zhao; Kaijie Yang; Jinlong He; Yun Jin; Haibo Yang; Dong Ding; Qunhua Jin
Journal:  BMJ Open       Date:  2021-02-26       Impact factor: 2.692

6.  Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.

Authors:  Duan Wang; Hui Zhu; Wei-Kun Meng; Hao-Yang Wang; Ze-Yu Luo; Fu-Xing Pei; Qi Li; Zong-Ke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2018-03-15       Impact factor: 2.362

7.  Multiple-dose tranexamic acid for perioperative blood loss in total knee arthroplasty in patients with rheumatoid arthritis:a single-blinded, randomised, parallel-controlled study protocol in China.

Authors:  Bing-Xin Kang; Hui Xu; Chen-Xin Gao; Sheng Zhong; Jing Zhang; Jun Xie; Song-Tao Sun; Ying-Hui Ma; Wei-Tao Zhai; Lian-Bo Xiao
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.